The vaccine adjuvants market size has witnessed considerable growth in previous years, growing from$1.89 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. This growth in the historic period is attributed to increased vaccine development, prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, and globalization of vaccine distribution.
Moreover, the vaccine adjuvants market size is projected to display robust growth in the coming years, expected to expand to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period is foreseeable due to pandemic preparedness, expanding vaccine portfolio, global immunization goals, collaborations and partnerships, focus on therapeutic vaccines. Noteworthy trends during the forecast period include advancements in adjuvant technologies, focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, demand for safer and well-tolerated adjuvants, personalized vaccines and adjuvants.
Get Your Free Sample of The Global Vaccine Adjuvants Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp
What Are The Key Drivers Of The Vaccine Adjuvants Market?
A significant driver propelling the vaccine adjuvants market is the rising prevalence of infectious diseases. Infectious diseases caused by viruses, bacteria, fungi, or parasites require vaccines like hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis for effective treatment. As per the 2022 World Health Organization (WHO) report, an estimated 10.6 million people contracted tuberculosis globally in 2021, 1.6 million died, and 1.5 million were newly infected with HIV in 2021, which led to 650,000 casualties. Therefore, the rising prevalence of infectious diseases is a significant driver of the vaccine adjuvants market.
What Are The Major Segments of The Vaccine Adjuvants Market?
– By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
– By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
– By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
– By Disease: Cancer, Infectious Diseases, Other Diseases
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report
Who Are The Major Players In The Vaccine Adjuvants Market?
Companies of note currently operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation.
What Are The Emerging Trends In The Vaccine Adjuvants Market?
Product innovations are becoming an increasingly popular trend in the vaccine adjuvants market. For instance, in December 2022, Evonik Industries, a chemical manufacturing company based in Germany, launched PhytoSquene, a plant-based squalene derived from amaranth oil. This sustainable alternative to traditional shark-derived squalene is designed for use in vaccine adjuvants and other pharmaceutical applications, enhancing vaccine efficacy by boosting immune responses.
Which Region Has The Largest Share In The Vaccine Adjuvants Market?
In 2024, North America was the largest region in the vaccine adjuvants market. However, during the upcoming forecast period, Asia-Pacific is expected to emerge as the fastest-growing region. The report covers regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the vaccine adjuvants market.
What Does The Vaccine Adjuvants Market Report 2025 Offer?
Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body’s immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response. The Vaccine Adjuvants Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
